Quanterix Corporation Impairment of Long-Lived Assets Held-for-use
Quanterix Corporation (QTRX) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2023-11-08
- Quanterix Corporation impairment of long-lived assets held-for-use for the quarter ending 2023-06-30 was $0.00.
- Quanterix Corporation impairment of long-lived assets held-for-use for the quarter ending 2023-03-31 was $0.00.
- Quanterix Corporation impairment of long-lived assets held-for-use for the quarter ending 2022-12-31 was $8.70M.
- Quanterix Corporation impairment of long-lived assets held-for-use for the quarter ending 2022-09-30 was $16.90M.
- Quanterix Corporation impairment of long-lived assets held-for-use for fiscal 2021 was $0.00.
- Quanterix Corporation impairment of long-lived assets held-for-use for fiscal 2020 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 3 month as first filed | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 9 month as first filed | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $8.70M derived: sum of 3 quarters · filed 2023-08-08 | $25.60M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $8.70M derived: sum of 2 quarters · filed 2023-08-08 | $25.60M derived: sum of 3 quarters · filed 2023-11-08 | ||||
| 2022-12-31 | $8.70M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-08-08 | $25.60M derived: sum of 2 quarters · filed 2023-11-08 | $25.60M 10-Q · filed 2023-08-08 | $17.37M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $16.90M 10-Q · filed 2023-11-08 | $8.70M 10-Q · filed 2022-11-09 | $16.90M 10-Q · filed 2023-11-08 | $8.70M 10-Q · filed 2022-11-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-06 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |